Literature DB >> 2164160

Analysis of gain-of-function mutations of the lin-12 gene of Caenorhabditis elegans.

I Greenwald1, G Seydoux.   

Abstract

Certain cell fate decisions are specified by cell-cell interactions during the development of the nematode Caenorhabditis elegans. For example, in a wild-type hermaphrodite gonad, two cells, Z1.ppp and Z4.aaa, have the potential to become the anchor cell (AC). Intercellular communication establishes their fates and ensures that only one cell becomes the AC, while the other becomes a ventral uterine precursor cell (VU). One component of this intercellular communication seems to be the 'AC-to-VU' signal from the presumptive AC that causes the other cell to become a VU. Genetic and developmental studies indicated that the lin-12 gene specifies the fates of Z1.ppp and Z4.aaa. Molecular studies suggest that lin-12 directly participates in their communications, perhaps acting as the receptor for the 'AC-to-VU' signal. Here, we report the molecular lesions associated with lin-12 gain-of-function mutations, cell isolation experiments, and genetic studies of an unusual lin-12 allele. These data suggest that self-association of the putative lin-12-encoded receptor leads to its activation, and that certain gain-of-function mutations result in ligand-independent activation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2164160     DOI: 10.1038/346197a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  49 in total

Review 1.  The notch pathway: modulation of cell fate decisions in hematopoiesis.

Authors:  K Ohishi; B Varnum-Finney; I D Bernstein
Journal:  Int J Hematol       Date:  2002-06       Impact factor: 2.490

2.  Molecular basis of loss-of-function mutations in the glp-1 gene of Caenorhabditis elegans.

Authors:  V Kodoyianni; E M Maine; J Kimble
Journal:  Mol Biol Cell       Date:  1992-11       Impact factor: 4.138

3.  New positive regulators of lin-12 activity in Caenorhabditis elegans include the BRE-5/Brainiac glycosphingolipid biosynthesis enzyme.

Authors:  Iskra Katic; Laura G Vallier; Iva Greenwald
Journal:  Genetics       Date:  2005-09-12       Impact factor: 4.562

4.  Notch subunit heterodimerization and prevention of ligand-independent proteolytic activation depend, respectively, on a novel domain and the LNR repeats.

Authors:  Cheryll Sanchez-Irizarry; Andrea C Carpenter; Andrew P Weng; Warren S Pear; Jon C Aster; Stephen C Blacklow
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

5.  Cell fate-specific regulation of EGF receptor trafficking during Caenorhabditis elegans vulval development.

Authors:  Attila Stetak; Erika Fröhli Hoier; Assunta Croce; Giuseppe Cassata; Pier Paolo Di Fiore; Alex Hajnal
Journal:  EMBO J       Date:  2006-05-11       Impact factor: 11.598

6.  Interallelic complementation among DER/flb alleles: implications for the mechanism of signal transduction by receptor-tyrosine kinases.

Authors:  E Raz; E D Schejter; B Z Shilo
Journal:  Genetics       Date:  1991-09       Impact factor: 4.562

Review 7.  Deregulated NOTCH signaling in acute T-cell lymphoblastic leukemia/lymphoma: new insights, questions, and opportunities.

Authors:  Jon C Aster
Journal:  Int J Hematol       Date:  2005-11       Impact factor: 2.490

8.  Integration of EGFR and LIN-12/Notch Signaling by LIN-1/Elk1, the Cdk8 Kinase Module, and SUR-2/Med23 in Vulval Precursor Cell Fate Patterning in Caenorhabditis elegans.

Authors:  Ryan S Underwood; Yuting Deng; Iva Greenwald
Journal:  Genetics       Date:  2017-09-27       Impact factor: 4.562

9.  Intragenic dominant suppressors of glp-1, a gene essential for cell-signaling in Caenorhabditis elegans, support a role for cdc10/SWI6/ankyrin motifs in GLP-1 function.

Authors:  J L Lissemore; P D Currie; C M Turk; E M Maine
Journal:  Genetics       Date:  1993-12       Impact factor: 4.562

10.  Effects of S1 cleavage on the structure, surface export, and signaling activity of human Notch1 and Notch2.

Authors:  Wendy R Gordon; Didem Vardar-Ulu; Sarah L'Heureux; Todd Ashworth; Michael J Malecki; Cheryll Sanchez-Irizarry; Debbie G McArthur; Gavin Histen; Jennifer L Mitchell; Jon C Aster; Stephen C Blacklow
Journal:  PLoS One       Date:  2009-08-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.